Abstract
Currently, allergies are among the most common pathological conditions in children. According to epidemiological studies, up to 25% of children and adolescents suffer from allergic diseases (AD). Once developed, allergies pose a risk of severe allergic reactions that can be life-threatening. Allergic diseases (AD) also reduce the quality of life for children and adolescents. Proper control of these conditions requires significant financial expenditures from both society as a whole and families with children affected by allergies.